Hypertension · Nov 18, 2026

2025 Harriet Dustan Lecture: Sex Differences in Immune-Mediated Hypertension: Why Menopause Matters

By Brooks HL, Sylvester MA, Michea L

Hypertension is an inflammatory disease with the immune system playing a key role in mediating hypertensive outcomes and end-organ damage. The risk of hypertension is greater in men than in women before women enter menopause. After menopause, a woman’s risk for developing hypertension increases and accelerates beyond that of age-matched men. Moreover, after menopause, the rate of hypertension control in women is lower than in men. Indeed, cardiovascular drug efficacy in women is different from that in men, with recent studies highlighting serious side effects of angiotensin-converting enzyme inhibitors and β-blockers in postmenopausal women. Despite these sex differences, sex-specific clinical practice guidelines are still sparse, as is the consideration of a woman’s hormonal status. In addition, preclinical models of immune-mediated hypertension are still mainly performed in male animals. The goal of this review is to highlight recent advancements in the field of sex differences in immune-mediated hypertension and to identify the major gaps in understanding immune mechanisms that lead to hypertension development in males and females, and as menopause progresses.

doi.org/10.1161/hypertensionaha.126.26079PubMed 43046968Mechanisms

AgingResearch.News